{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:25:54Z","timestamp":1789349154213,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ejphar.2011.11.052","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T01:20:46Z","timestamp":1323912046000},"page":"34-40","source":"Crossref","is-referenced-by-count":17,"title":["Effect of atorvastatin with or without prednisolone on Freund's adjuvant induced-arthritis in rats"],"prefix":"10.1016","volume":"676","author":[{"given":"Amany A.","family":"Abdin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Abd El-Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabiha E.","family":"Hedeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira A.E.","family":"El-Saadany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.11.052_bb0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/rheumatology\/keg083","article-title":"Rheumatoid arthritis and macrovascular disease","volume":"42","author":"Alkaabi","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/hrt.80.6.543","article-title":"Cholesterol lowering and coronary artery disease: mechanisms of risk reduction","volume":"80","author":"Archbold","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0015","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0020","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(98)00272-X","article-title":"Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidant","volume":"26","author":"Aviram","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejphar.2005.05.005","article-title":"Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis","volume":"516","author":"Barsante","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0030","doi-asserted-by":"crossref","first-page":"927","DOI":"10.18388\/abp.2002_3752","article-title":"Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration","volume":"49","author":"Beltowski","year":"2002","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.190.4.585","article-title":"The major receptor for C reactive protein on leukocytes is FC-\u03b3 receptor II","volume":"190","author":"Bharadwaj","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0040","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/ard.62.11.1033","article-title":"Glucocorticoids in the treatment of early and late RA","volume":"62","author":"Bijlsma","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0045","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","article-title":"Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis","volume":"62","author":"Boers","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0050","doi-asserted-by":"crossref","first-page":"C198","DOI":"10.1152\/ajpcell.00045.2010","article-title":"Adipogenic and lipolytic effects of chronic glucocorticoid exposure","volume":"300","author":"Campbell","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0055","first-page":"62","article-title":"The comparison of oxidant and antioxidant parameters in inflamed paw tissue formed by carrageenan injection in intact and adrenalectomized rats","volume":"34","author":"\u00c7andar","year":"2009","journal-title":"Turk. J. Biochem."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-2275(20)38176-1","article-title":"Effects of adrenalectomy and dexamethasone on hepatic lipid metabolism","volume":"23","author":"Cole","year":"1982","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0065","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0891-5849(96)00389-9","article-title":"A modified form of low density lipoprotein with increased electronegative charge is present in rheumatoid arthritis synovial fluid","volume":"22","author":"Dai","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0070","first-page":"1856","article-title":"Use of low dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis","volume":"32","author":"Davis","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.RES.83.7.683","article-title":"3-Hydroxy-3-methylgluteryl coenzyme(HMG)-CoA reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells, role of geranyl geranylation and Rho proteins","volume":"83","author":"Essig","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0080","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","article-title":"Serum triglycerides determined colometrically with an enzyme that produces hydrogen peroxide","volume":"28","author":"Fossati","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3181\/00379727-49-13625","article-title":"Sensitization to horse serum by means of adjuvants","volume":"49","author":"Freund","year":"1942","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0090","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0009-9120(96)00007-0","article-title":"Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis","volume":"30","author":"Gambhir","year":"1997","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0100","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar1952","article-title":"Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment \u2014 a prospective, controlled study","volume":"8","author":"Georgiadis","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semarthrit.2007.09.008","article-title":"Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients","volume":"38","author":"Georgiadis","year":"2008","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0115","first-page":"515","article-title":"Short-term effect of dexamethasone on fatty acid and cholesterol synthesis in isolated rat hepatocytes","volume":"44","author":"Giudetti","year":"1998","journal-title":"Biochem. Mol. Biol. Int."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0110","first-page":"1219","article-title":"High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/301691","article-title":"Paraoxonase gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?","volume":"62","author":"Heincke","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharmthera.2009.06.008","article-title":"Lipids as targets for novel anti-inflammatory therapies","volume":"124","author":"Huwiler","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0130","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0002-9149(00)01430-2","article-title":"Comparison of efficiency and safety of atorvastatin (10mg) with simvastatin (10mg) at six weeks","volume":"87","author":"Insull","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.berh.2008.11.007","article-title":"Cardiovascular co-morbidity in early rheumatoid arthritis","volume":"23","author":"John","year":"2009","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0140","first-page":"2597","article-title":"Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis","volume":"28","author":"Jonsson","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0145","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/bbrc.1999.0799","article-title":"HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthesis mRNA","volume":"259","author":"Kanno","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s002239900107","article-title":"Effects of continuous glucocorticoid infusion on bone metabolism in the rat","volume":"59","author":"King","year":"1996","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0410","first-page":"CD006356","article-title":"Effects of glucocorticoids on radiological progression in rheumatoid arthritis","volume":"1","author":"Kirwan","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0160","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.CIR.0000086460.55494.AF","article-title":"Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin","volume":"108","author":"Kleemann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0165","first-page":"119","article-title":"Serum interleukin 6 (Il-6) concentration correlates with matrix mettaloproteinases and their tissue inhibitors in rheumatoid arthritis","volume":"109","author":"Klimiuk","year":"2003","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0170","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/79510","article-title":"The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals","volume":"6","author":"Kureishi","year":"2000","journal-title":"Nat. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2011.11.052_bb0175","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0180","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0022-2275(20)41133-2","article-title":"Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters","volume":"36","author":"Ly","year":"1995","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/ard.59.5.321","article-title":"Inflammation-mediated rheumatic diseases and atherosclerosis","volume":"59","author":"Manzi","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0192-0561(99)00088-0","article-title":"Effect of FTY720, a novel immunosuppressant, on adjuvant and collagen induced arthritis in rats","volume":"22","author":"Matsuura","year":"2000","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0195","first-page":"761","article-title":"Serum esterase activity in reactive systemic amyloidosis and its relation to amyloid A degrading activity","volume":"104","author":"Maury","year":"1984","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0415","series-title":"AHFS Drug Information","first-page":"1681","article-title":"HMG-CoA reductase inhibitors. Atorvastatin","year":"2006"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cccn.2003.12.030","article-title":"Relationship between platelets and inflammatory markers in rheumatoid arthritis","volume":"343","author":"Milovanoic","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathology and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0220","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000115363","article-title":"11beta-hydroxysteroid dehydrogenase type 1 and obesity","volume":"36","author":"Morton","year":"2008","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0225","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1734-1140(09)70146-X","article-title":"Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status","volume":"61","author":"Nagila","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0230","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0235","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.berh.2007.05.003","article-title":"Mortality in established rheumatoid arthritis","volume":"21","author":"Naz","year":"2007","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0240","first-page":"889","article-title":"Evaluating the efficacy and tolerance of atorvastatin in hyperlipidemia in general practice (SWITCH Study)","volume":"130","author":"Noseda","year":"2000","journal-title":"Schweiz. Med. Wochenschr."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0245","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.autrev.2009.02.015","article-title":"Cardiovascular risk in rheumatoid arthritis","volume":"8","author":"Nurmohamed","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0250","first-page":"964","article-title":"Beneficial action of statins in patient with rheumatoid arthritis in a large observational cohort","volume":"34","author":"Okamoto","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0255","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1056-8727(02)00245-3","article-title":"Cerivastatin ameliorates high insulin-enhanced neutrophil\u2013endothelial cell adhesion and endothelial intercellular adhesion molecule-1 expression by mitogen-activated protein kinase activation","volume":"17","author":"Okouchi","year":"2003","journal-title":"J. Diab. Complications"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0260","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/clinchem\/28.10.2121","article-title":"Turbidimetric immunoassay of serum C-reactive protein","volume":"28","author":"Otsuji","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0265","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-9120(94)00081-6","article-title":"Correlation between plasma malondialdehyde and ceruloplasmin activity values in rheumatoid arthritis","volume":"28","author":"Ozgunes","year":"1995","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0270","first-page":"1701","article-title":"Lipid profiles in untreated patients with rheumatoid arthritis","volume":"26","author":"Park","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0275","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1529-0131(195910)2:5<440::AID-ART1780020510>3.0.CO;2-N","article-title":"Studies on polyarthritis and other lesions induced in rats by injection of mycobacterium adjuvant. I. General clinical and pathological characteristics and some modifying factors","volume":"2","author":"Pearson","year":"1959","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-136-1-200201010-00013","article-title":"Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?","volume":"136","author":"Pincus","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0285","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/01.CIR.0000111128.83347.7A","article-title":"Differential modulation of caveolin-1expression in cells of the vasculature by statins","volume":"109","author":"Plenz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0290","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/rheumatology\/kep096","article-title":"Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis","volume":"48","author":"Ravindran","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0295","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/clinchem\/19.12.1350","article-title":"Enzymatic determination of cholesterol","volume":"19","author":"Richmond","year":"1973","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0300","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2009.07.015","article-title":"Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-na\u0457ve patients with early rheumatoid arthritis","volume":"207","author":"Rizzo","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0310","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1067\/mhj.2000.108245","article-title":"Effects of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized placebo controlled study","volume":"140","author":"Schrott","year":"2000","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0315","first-page":"1922","article-title":"Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis","volume":"22","author":"Stefanovic-Racic","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0320","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"Stumvoll","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0325","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma cholesteryl ester transfer protein","volume":"34","author":"Tall","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0330","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/S0024-3205(03)00195-4","article-title":"Serum paraoxonase activity decrease in rheumatoid arthritis","volume":"72","author":"Tanimoto","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0335","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/ard.2003.013243","article-title":"MMP profile in paired serum and synovial fluid samples in patients with rheumatoid arthritis","volume":"63","author":"Tchetverikov","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0340","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/01.CIR.103.18.2283","article-title":"High density lipoprotein loses its anti-inflammatory properties during acute influenza a infection","volume":"103","author":"Van Lenten","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/kem202","article-title":"Systemic inflammation as a risk factor for atherothrombosis","volume":"47","author":"van Leuven","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0355","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2362.2008.02067.x","article-title":"Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?","volume":"39","author":"Van Raalte","year":"2009","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0350","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/rheumatology\/39.9.1004","article-title":"Nitric oxide is a mediator of apoptosis in the rheumatoid joint","volume":"39","author":"van't Hof","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0360","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjp.0704678","article-title":"Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ","volume":"136","author":"Wagner","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0365","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.mehy.2003.11.040","article-title":"Rheumatoid arthritis increases the risk of coronary heart disease via vascular endothelial injuries","volume":"63","author":"Wang","year":"2004","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0370","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0009-8981(60)90004-8","article-title":"A simple method for the determination of serum cholesterol","volume":"5","author":"Watson","year":"1960","journal-title":"Clin. Chem. Acta"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0375","first-page":"U2125","article-title":"Atherogenic lipid profiles in rheumatoid arthritis","volume":"119","author":"White","year":"2006","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0380","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/ard.52.9.677","article-title":"Presence of foam cells containing oxidized low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis","volume":"52","author":"Winyard","year":"1993","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0385","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0076-6879(84)05042-4","article-title":"Assay for blood plasma or serum lipid peroxides","volume":"105","author":"Yagi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0390","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2249.1998.00438.x","article-title":"Glucocorticoid inhibition of adjuvant arthritis synovial macrophages nitric oxide production: role of lipocortin 1","volume":"111","author":"Yang","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0395","first-page":"423","article-title":"Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis","volume":"34","author":"Yildirim","year":"2004","journal-title":"Ann. Clin. Sci."},{"key":"10.1016\/j.ejphar.2011.11.052_bb0400","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cca.2005.08.006","article-title":"Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocyte of hypercholesterolemic rabbits","volume":"365","author":"Zhao","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2011.11.052_bb0405","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1007017509008","article-title":"Effects of atorvastatin treatment on the oxidatively modified low density lipoprotein in hyperlipidemic patients","volume":"207","author":"Zhu","year":"2000","journal-title":"Mol. Cell. Biochem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911015202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911015202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T21:24:43Z","timestamp":1742073883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911015202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":81,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0014299911015202"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.11.052","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}